Related Experiment Video
Updated: Jun 4, 2026
07:13
Orienteering as a Tool for Cognitive Research: An Implementation Guide
Published on: November 29, 2024
Cardiovascular prevention of cognitive decline
Jean-Jacques Monsuez1, Aude Gesquière-Dando, Sofia Rivera
1AP-HP, Hôpital René Muret, Hôpitaux Universitaires de Paris Seine-Saint-Denis, Policlinique Médicale, Avenue du Docteur Schaeffner, 93270 Sevran, France.
Cardiology Research and Practice
|February 15, 2011
Summary
Managing midlife cardiovascular risks like hypertension and diabetes can prevent or delay dementia. Optimal treatment of these factors is crucial for cognitive health and slowing cognitive decline.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Midlife cardiovascular risk factors (diabetes, hypertension, dyslipidemia, unhealthy lifestyle) are associated with Alzheimer's disease and vascular dementia.
- Optimal management of cardiovascular risks can prevent and slow age-related cognitive disorders.
Purpose of the Study:
- To assess the impact of antihypertensive therapy on cognitive outcomes in hypertensive patients.
- To evaluate the role of statin use in dementia incidence.
- To determine if a multi-targeted intervention can improve cognitive protection in lower-risk populations.
Main Methods:
- Review of large clinical trials on antihypertensive therapy and cognitive outcomes.
- Analysis of large-scale databases correlating statin use with dementia incidence.
- Proposal for appropriately designed trials for multi-targeted interventions.
Main Results:
- Antihypertensive therapy trials showed reduced white matter hyperintensities, cognitive decline, and dementia incidence.
- Database studies suggested statin use reduced dementia incidence, particularly in patients with atherosclerosis.
- Clinical trials did not consistently support statin benefits for dementia.
Conclusions:
- Cardiovascular risk factor management is vital for preventing and delaying dementia.
- Antihypertensive therapy demonstrates cognitive benefits.
- Further large-scale trials are needed to ascertain the efficacy of multi-targeted interventions for cognitive protection in broader populations.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:27Psychoneuroimmunology: Cardiovascular Disease
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...